You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BBIO Exercise Disclosure
Kumar Neil · SEC Form 4 · Filed Aug 18, 2026
Exercise
Reported value range
Not reported
Kumar Neil Chief Executive Officer
BBIO
BridgeBio Pharma
BBIO
Transaction date
Aug 16, 2026
Public filing date
Aug 18, 2026
Filing lag
Filed 2 days later
BBIO daily price context
Close on/before transaction
$79.86
Aug 14, 2026
First close after public filing
$83.95
Aug 19, 2026
30-day return after filing
-19.82%
Through Sep 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 19,599 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001470831-26-000836
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$2.89M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bridgebio Pharma, Inc. BBIO | Exercise | Aug 16, 2026 | Not reported |
| Bridgebio Pharma, Inc. BBIO | Exercise | Aug 16, 2026 | Not reported |
| Bridgebio Pharma, Inc. BBIO | Disposition | Aug 16, 2026 | $2.89M |
| Bridgebio Pharma, Inc. BBIO | Exercise | Aug 16, 2026 | Not reported |
| Bridgebio Pharma, Inc. BBIO | Exercise | Aug 16, 2026 | $0 |
| Bridgebio Pharma, Inc. BBIO Current | Exercise | Aug 16, 2026 | Not reported |
| Bridgebio Pharma, Inc. BBIO | Exercise | Aug 16, 2026 | $0 |
| Bridgebio Pharma, Inc. BBIO | Exercise | Aug 16, 2026 | $0 |
| Bridgebio Pharma, Inc. BBIO | Exercise | Aug 16, 2026 | $0 |